Combined treatment with cisplatin and the tankyrase inhibitor XAV-939 increases cytotoxicity, abrogates cancer-stem-like cell phenotype, and increases chemosensitivity of head-and-neck squamous-cell carcinoma cells
In conclusion, this study elucidated that combination of cisplatin and XAV-939 exerted cytotoxic and genotoxic effect to abrogate CSC mediated chemoresistance in HNSCC in synergistic manner.
Source: Mutation Research Genetic Toxicology and Environmental Mutagenesis - Category: Genetics & Stem Cells Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Environmental Health | Gastroschisis Repair | Genetics | Head and Neck Cancer | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology